Lipodystrophy
Rare Disease·MeSH: Lipodystrophy, Congenital Generalized
Prevalence
0.1 / 100K
5 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| Waylivra | PTC THERAPEUTICS, INC. (PTCT) |
Phase 3(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Lipodystrophy?
BioSniper tracks 5 drugs in development for Lipodystrophy across 2 companies.
How many clinical trials target Lipodystrophy?
There are 1 clinical trial targeting Lipodystrophy tracked by BioSniper.
What is the prevalence of Lipodystrophy?
The estimated prevalence of Lipodystrophy is approximately 0.1 per 100,000 population.
Deep-dive into Lipodystrophy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis